The FDA has approved Pfizer's BCMAxCD3 bispecific antibody Elrexfio as another off-the-shelf treatment option for people with multiple myeloma who have exhausted at least four prior lines of therapy.

Pfizer will relinquish its stake in ViiV Healthcare in a deal valued at just over $2.1 billion that ramps up Shionogi's interest and simplifies the shareholder structure of the HIV specialist. Under ...

Pfizer limits seven drugs to medical buyers on October 15, 2026. Pfizer stock costs EUR 26.25 on October 15, 2026 versus EUR ...

However, the study found that a third dose of the Pfizer vaccine, and mixing Pfizer and AstraZeneca preventives may protect ...

Gdansk: Teva ​said on Friday it had received approval ‌from the US Food and Drug Administration for Weltruza, a once-monthly ...

This Week's Global Pharma News] Roche and Pfizer Receive US FDA Approvals, argenx Discontinues Phase 3 Trial, New ...

This slide details the implications of Pfizer's announcement to restrict the sale of drugs that could be used for lethal injection ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Bengaluru: The Special Investigation Team (SIT) probing an alleged counterfeit pharmaceutical racket in Karnataka has ...

The SIT investigating the alleged fake pharmaceutical racket helmed by a former medical representative based in Karnataka has said that the probe traced overseas links in Turkiye who supplied original ...